Skip to content
www.elpa.eu
MENUMENU
  • HOME
  • DISCOVER
    • Our Mission
    • ANNUAL REPORTS
    • Statutes
    • Our team
    • Internal rules
    • FINANCES
    • Governance
    • Best practice
    • Codes of conduct
    • Finance and transparency
    • SUPPORTS AND GRANTS
    • Resource library
    • European social charter
    • QUARTAL NEWS REPORT
    • ELPA supporters, collaboration and partnership
    • Statutory Audit
    • Endorsement documents
    • ISO Certificate
  • MEMBERS
    • ELPA MEMBERS
    • BECOME A MEMBER
    • BECOME A SUPPORTER
  • PROJECTS
    • Hep-CORE Study
    • ELPA UNIVERSITY
    • Hep C – From Hell to Hope
    • ELPA INTERVIEWS
    • ELPA@HOME
    • Spring European HEPATIS-HIV Testing Week
    • Spring European Testing Week
    • Time To DeLiver
  • RESEARCH
    • EIT LIVERSCREEN
    • MICROB-PREDICT
    • Liverhope
    • IP cure B
    • DECISION
    • Galaxy
    • COBALT Study
  • LIVER DISEASES
    • Hepatic encephalopathy (HE)
    • Hepatitis B (HBV)
    • Hepatitis C (HCV)
    • Hepatocellular carcinoma (HCC)
    • Nonalcoholic steatohepatitis (NASH)
    • Rare liver diseases
    • Liver Cancer
      • EU Projects
  • NEWS
  • MEDIA CORNER
  • CALENDAR

1st Liver Cancer Patients’ Summit – Key messages

Posted on February 24, 2021 | by admin

1st Liver Cancer Patients' Summit - Key messages

1st Liver Cancer Patients' Summit - Key messages
Posted in Elpa News

Post navigation

ELPA was honoured to participate in dissemination of the information and results of research project Liver Screen that was funded by EITHealth The biggest liver screening project Europe “LiverScreen: before it’s too late”
We are proud to be part of PWCR #EMA European Medical Agency

Our ultimate goal is a world without liver disease.

For any information related to our association please contact us.

© ELPA - Schuman Roundabout 2-4, Level 6,1040 Brussels, Belgium

© 2022 www.elpa.eu | Bootstrap WordPress Theme